PATENT CLAIM ANALYSIS

Application Number: 15866749
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "093700"]

Abstract:
The use of a medical therapeutic ozone agent in vivo to treat a variety of disorders including, but not limited to hypoxic conditions, autoimmune disease, fibrotic disease, inflammatory disease, neurodegenerative disease, infectious disease, lung disease, heart and vascular disease, metabolic disease, and cancer, wherein the therapeutic ozone agent is administered in a therapeutically effective amount, which can convert carbon monoxide to carbon dioxide, thereby treating or preventing the disease in a patient.

Claim (Index 3):
The method of  claim 1 , wherein the a therapeutic ozone agent is administered by a method selected from the group consisting of rectal insufflation, extracorporeal treatment and re-administration of the patient's blood, intramuscular administration, cardiopulmonary bypass, and combinations thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.65385
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15825982', '14451232', '15471123', '12009649', '15311635']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650321384386726
- 35 USC 102 Novelty (BERT): 0.4901770556730898
- Combined Prediction Score: 0.7375466301621143
- Mean Citation Score: 189.346422
- Max Citation Score: 196.74686
- Similarity Product: 135.5680171334243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test